Revisions for Dapsone

Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.

RevisionOperations
02-13-25 by ripal121current revision
02-7-25 by ripal121

ripal121 replaced Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module.

02-7-25 by ripal121

ripal121 replaced Intermittent HD with Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min. via Scanner Search and Replace module.

02-7-25 by conan.macdougal...

[email protected] replaced For detailed view of dialysis dosing and evidence, see <a href="https://idmp.ucsfsitebuilder.acsitefactory.com/content/ucsf-adult-antimicrobial-dosing-dialysis-reference-document">Dosing in Hemodialysis</a> document.</p> with via Scanner Search and Replace module.

02-4-25 by ripal121
12-10-24 by ripal121
12-10-24 by ripal121
11-26-24 by ripal121
11-26-24 by ripal121
11-26-24 by ripal121
11-25-24 by ripal121
11-25-24 by ripal121

Dosing: Adult Antimicrobial Dosing, Non-dialysis

Indication Dose Notes

 Pneumocystis pneumonia (PROPHYLAXIS)

100 mg PO Q24H 

Use in patients who are intolerant of sulfa

No renal adjustment 

Rule out G6PD deficiency prior to treatment initiation

Dapsone monotherapy does not provide prophylaxis for Toxoplasmosis

Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis

Indication Dose Notes

 Pneumocystis pneumonia (PROPHYLAXIS)

100 mg PO Q24H 

Use in patients who are intolerant of sulfa

No renal adjustment 

Rule out G6PD deficiency prior to treatment initiation

Dapsone monotherapy does not provide prophylaxis for Toxoplasmosis

Dialysis Notes

References: